Li Xie

机构：East China Jiaotong University, Guangxi Medical University, Capital Medical University, Sichuan University, Beijing Institute of Optoelectronic Technology, West China Hospital of Sichuan University, Beijing Chest Hospital, First Affiliated Hospital of GuangXi Medical University, NKT Therapeutics (United States) · ORCID：0000-0003-0303-1542

发表论文 43 篇 · 总被引 728 次 · h-index 11

代表论文

• Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude (2022 · Blood · 被引 76)
• An independently validated nomogram for individualised estimation of short-term mortality risk among patients with severe traumatic brain injury: a modelling analysis of the CENTER-TBI China Registry Study (2023 · EClinicalMedicine · 被引 28)
• TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1 (2024 · International Journal of Biological Sciences · 被引 21)
• Investigation of the association between ten pathogens causing sexually transmitted diseases and high‑risk human papilloma virus infection in Shanghai (2021 · Molecular and Clinical Oncology · 被引 19)
• LBA60 Phase III study of SHR-1701 versus placebo in combination with chemo as first-line (1L) therapy for HER2-negative gastric/gastroesophageal junction adenocarcinoma (G/GEJA) (2024 · Annals of Oncology · 被引 14)
• Evaluation of Molecular Point-of-Care Testing for Respiratory Pathogens in Children With Respiratory Infections: A Retrospective Case-Control Study (2021 · Frontiers in Cellular and Infection Microbiology · 被引 10)